Desidustat is an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor used in the treatment of anemia associated with chronic kidney disease. By stabilizing the hypoxia-inducible factor,… Read more
Desidustat is an orally active hypoxia-inducible factor prolyl hydroxylase inhibitor used in the treatment of anemia associated with chronic kidney disease. By stabilizing the hypoxia-inducible factor, this small molecule drug stimulates erythropoietin production to enhance red blood cell formation. This category provides access to high-quality reference standards, including Desidustat, its process-related impurities, and stable isotope labelled compounds such as deuterated Desidustat. These materials are critical for researchers and analytical chemists conducting impurity profiling, method validation, and rigorous quality control within pharmaceutical development. Laboratories rely on these specific reference materials to ensure accurate quantification of the active pharmaceutical ingredient and its degradation products during stability testing and routine analysis, particularly when utilizing techniques like liquid chromatography-mass spectrometry to monitor and control impurity levels throughout the drug manufacturing lifecycle.